These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 438528)

  • 1. Circulating immune complexes in experimental streptococcal endocarditis: a monitor of therapeutic efficacy.
    Bayer AS; Theofilopoulos AN; Dixon FJ; Guze LB
    J Infect Dis; 1979 Jan; 139(1):1-8. PubMed ID: 438528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental Streptococcus sanguis endocarditis: immune complexes and renal involvement.
    Thörig L; Daha MR; Eulderink F; Kooy-Bauer WC; Thompson J
    Clin Exp Immunol; 1980 Jun; 40(3):469-77. PubMed ID: 7418263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fate of circulating immune complexes in infective endocarditis.
    Cabane J; Godeau P; Herreman G; Acar J; Digeon M; Bach JF
    Am J Med; 1979 Feb; 66(2):277-82. PubMed ID: 154840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial circulating immune complexes and mononuclear phagocyte system function in infective endocarditis.
    Schned ES; Inman RD; Parris TM; Kimberly RP; Redecha PB; Christian CL
    J Lab Clin Med; 1983 Dec; 102(6):947-59. PubMed ID: 6227674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nitrogen mustard on natural history of right-sided streptococcal endocarditis in rabbits: role for cellular host defenses.
    Yersin BR; Glauser MP; Freedman LR
    Infect Immun; 1982 Jan; 35(1):320-5. PubMed ID: 7054124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating immune complexes in infective endocarditis.
    Bayer AS; Theofilopoulos AN; Eisenberg R; Dixon FJ; Guze LB
    N Engl J Med; 1976 Dec; 295(27):1500-5. PubMed ID: 995157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The heterogeneity of Streptococcus viridans: therapeutic considerations in infective endocarditis.
    Fisher J; Levene DL
    Can Med Assoc J; 1975 May; 112(10):1217-9. PubMed ID: 1125890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nature of circulating immune complexes in infective endocarditis.
    Burton-Kee J; Morgan-Capner P; Mowbray JF
    J Clin Pathol; 1980 Jul; 33(7):653-9. PubMed ID: 7430371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental group B streptococcal endocarditis treated with penicillin G versus ceftizoxime. In vitro-in vivo disparity.
    Bayer AS; Morrison JO; Kim KS
    Chemotherapy; 1983; 29(5):352-61. PubMed ID: 6311493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical implications and the pathogenetic significance of circulating immune complexes in infective endocarditis.
    Kauffmann RH; Thompson J; Valentijn RM; Daha MR; Van Es LA
    Am J Med; 1981 Jul; 71(1):17-25. PubMed ID: 7246577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of bacterial antigens in circulating immune complexes of infective endocarditis.
    Inman RD; Redecha PB; Knechtle SJ; Schned ES; van de Rijn I; Christian CL
    J Clin Invest; 1982 Aug; 70(2):271-80. PubMed ID: 6808025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic parameters in infective endocarditis: a prospective study.
    Agarwal R; Bahl VK; Malaviya AN; Krishnan S; Chopra P
    Indian Heart J; 1991; 43(3):179-83. PubMed ID: 1800304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy of experimental streptococcal endocarditis. II. Synergism between penicillin and streptomycin against penicillin-sensitive streptococci.
    Durack DT; Pelletier LL; Petersdorf RG
    J Clin Invest; 1974 Mar; 53(3):829-33. PubMed ID: 4492776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of tissue-type plasminogen activator (t-PA) on the treatment with benzylpenicillin of rabbits with experimental Streptococcus sanguis endocarditis.
    Buiting AG; Thompson J; Emeis JJ; Mattie H; Brommer EJ; van Furth R
    J Infect Dis; 1989 Apr; 159(4):780-4. PubMed ID: 2494270
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of granulocytes in the prevention and therapy of experimental Streptococcus sanguis endocarditis in rabbits.
    Meddens MJ; Thompson J; Mattie H; van Furth R
    Antimicrob Agents Chemother; 1984 Feb; 25(2):263-7. PubMed ID: 6712203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infective endocarditis-associated glomerulonephritis in rabbits: evidence of a pathogenetic role for antiglobulins.
    Sindrey M; Barratt J; Hewitt J; Naish P
    Clin Exp Immunol; 1981 Aug; 45(2):253-60. PubMed ID: 7032767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment with vancomycin of experimental endocarditis caused by Streptococcus sanguis II resistant to penicillin].
    Martínez F; Martín Luengo F; Valdés M
    Enferm Infecc Microbiol Clin; 1993 May; 11(5):255-9. PubMed ID: 8324022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the immune response in protection against experimental Streptococcus defectivus endocarditis.
    Sieling PA; van de Rijn I
    J Lab Clin Med; 1991 May; 117(5):402-9. PubMed ID: 2019795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy of experimental streptococcal endocarditis. I. Comparison of commonly recommended prophylactic regimens.
    Durack DT; Petersdorf RG
    J Clin Invest; 1973 Mar; 52(3):592-8. PubMed ID: 4685083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffuse glomerulonephritis in rabbits with Streptococcus viridans endocarditis.
    Arnold SB; Valone JA; Askenase PW; Kashgarian M; Freedman LR
    Lab Invest; 1975 Jun; 32(6):681-9. PubMed ID: 125360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.